These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23497933)

  • 1. [Primary lateral sclerosis and lung adenocarcinoma].
    Martinez L; Lamaze R; Clément-Duchêne C
    Rev Mal Respir; 2013 Mar; 30(3):227-30. PubMed ID: 23497933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of adenocarcinoma of the lung with malignant pleural effusion in elderly patient treated effectively by pemetrexed and carboplatin].
    Tada A; Sakaguchi K; Kobayashi M; Kagoshima T; Yamazaki Y; Kamisawa O
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):425-7. PubMed ID: 22421772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of lung cancer in an elderly patient with malignant pleural effusion and pneumothorax treated with carboplatin, pemetrexed, and bevacizumab].
    Miyahara E; Itagaki T; Kuwahara M; Kameda A; Oue N
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1237-40. PubMed ID: 25335706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of systemic chemotherapy in a patient with mitochondrial myopathy and non-small-cell lung cancer.
    Catania C; Spitaleri G; Delmonte A; Giovannini M; Toffalorio F; Noberasco C; Bresolin N; Comi G; De Pas T
    J Clin Oncol; 2012 Aug; 30(24):e226-8. PubMed ID: 22711848
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete radiological response of metastatic anaplastic lymphoma kinase-positive signet ring lung adenocarcinoma to systemic chemotherapy.
    Korpanty G; Mulligan N; Carney DN
    J Thorac Oncol; 2011 May; 6(5):963-5. PubMed ID: 21623269
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of Carboplatin and pemetrexed combination chemotherapy for synchronous double cancers of hepatocellular carcinoma and primary lung cancer].
    Okamoto E; Sato J; Sema M; Hayasaka J; Watanabe A; Takagi K; Kusano-Kitazume A; Tamura A; Kondo M; Sakuranaka H; Ochi J; Hanada S; Tanaka M; Akita H; Tei S; Ichioka M; Shibayama T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2154-6. PubMed ID: 25731454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLC.
    Li S; Zhou F; Ren S; Zhou C
    Lung Cancer; 2014 May; 84(2):203-5. PubMed ID: 24636847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed as a possible cause of severe rhabdomyolysis in the treatment of lung cancer.
    Huang MS; Tsai JR; Shen MC; Chou SH; Yang CJ
    Lung Cancer; 2012 Jun; 76(3):491-2. PubMed ID: 22405568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116.
    Casey EM; Harb W; Bradford D; Bufill J; Nattam S; Patel J; Fisher W; Latz JE; Li X; Wu J; Hanna N
    J Thorac Oncol; 2010 Nov; 5(11):1815-20. PubMed ID: 20881647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case of pemetrexed-induced acute lung injury].
    Sakamoto S; Kaburaki K; Sakaguchi S; Sano G; Sugino K; Isobe K; Shibuya K; Kurosaki A; Uekusa T; Homma S
    Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):415-20. PubMed ID: 19514505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
    Rodrigues-Pereira J; Kim JH; Magallanes M; Lee DH; Wang J; Ganju V; Martínez-Barrera L; Barraclough H; van Kooten M; Orlando M
    J Thorac Oncol; 2011 Nov; 6(11):1907-14. PubMed ID: 22005471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous double primary lung cancers with different response to pemetrexed.
    Umemura S; Yamane H; Yano T; Hoshika T; Shiote Y; Takigawa N; Suwaki T; Shirakawa A; Kamei H
    Anticancer Drugs; 2011 Jun; 22(5):473-6. PubMed ID: 21346552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary lateral sclerosis with breast cancer, a potential paraneoplastic neurological syndrome].
    Corcia P; Honnorat J; Guennoc AM; de Toffol B; Autret A
    Rev Neurol (Paris); 2000 Nov; 156(11):1020-2. PubMed ID: 11119056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
    Smit EF; Burgers SA; Biesma B; Smit HJ; Eppinga P; Dingemans AM; Joerger M; Schellens JH; Vincent A; van Zandwijk N; Groen HJ
    J Clin Oncol; 2009 Apr; 27(12):2038-45. PubMed ID: 19307503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and motor neuron disease-causal or coincidental? Two contrasting cases.
    Goodfellow J; Gorrie G; Leach V; Patel S; Mackay G
    Neurol Sci; 2019 Jul; 40(7):1461-1463. PubMed ID: 30843116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer.
    Socinski MA; Raju RN; Stinchcombe T; Kocs DM; Couch LS; Barrera D; Rousey SR; Choksi JK; Jotte R; Patt DA; Periman PO; Schlossberg HR; Weissman CH; Wang Y; Asmar L; Pritchard S; Bromund J; Peng G; Treat J; Obasaju CK
    J Thorac Oncol; 2010 Dec; 5(12):1963-9. PubMed ID: 21102260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus associated with pemetrexed plus Carboplatin chemotherapy.
    González García A; Sifuentes Giraldo WA; Grillo Fernández E; Zea Mendoza A
    J Clin Rheumatol; 2014 Dec; 20(8):449-50. PubMed ID: 25417687
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythema gyratum repens as the initial manifestation of lung cancer.
    Serrão V; Martins A; Ponte P; Baptista J; Apetato M; Feio AB
    Eur J Dermatol; 2008; 18(2):197-8. PubMed ID: 18424390
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].
    Hama M; Komatsu Y; Hachiya T
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1877-9. PubMed ID: 22083202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients.
    Honoré PH; Joensen SJ; Olsen M; Hansen SH; Mellemgaard A
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):349-57. PubMed ID: 24934863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.